Menu
1. -
2. Pourquoi et quand consulter le cardiologue? Rôle du cardiologue dans la prise en charge du patient diabétique
3. No potential conflicts of interest
4. Maladies cardiovasculaires: fardeau humain et économique
5. in people with T2D
6. La cause principale de décès chez les diabétiques de type 2 sont les maladies CV
7. Despite improvement, all-cause mortality is still high in patients with T2D
8. Traiter le diabète signifie traiter le risque cardiovasculaire
9. Type 2 diabetes is a major and independent risk factor for both microvascular and macrovascular complications
10. facteurs de risque et maladie CV
11. Diabetes & CV risk of morbi-mortality
12. La santé en Suisse
13. Diabetes & CV risk (EMPA-REG-CANVAS)
14. Diabetes & CV risk of morbi-mortality (EMPA-REG)
15. Diabetes & CV risk of morbi-mortality (EMPA-REG)
16. Diabetes & CV risk of morbi-mortality (EMPA-REG) Insuffisance cardiaque
17. Diabetes & CV risk of morbi-mortality (CANVAS)
18. Diabetes & CV risk of morbi-mortality (DECLARE)
19. Diabetes & CV risk of morbi-mortality (DECLARE)
20. Diabetes & CV risk of morbi-mortality
21. Diabète & Cardiologue - Guidelines
22. Diabète & Cardiologue - Guidelines
23. Diabetes & CV risk of morbi-mortality
24. Diabetes & CV risk of morbi-mortality
25. Impact of cardiovascular risk-factor treatment in diabetes (1998-2010)
26. Impact of cardiovascular risk-factor treatment in diabetes (1998-2010)
27. Dyslipidaemias - Guidelines
28. Dyslipidaemias - Guidelines
29. Statins - The evidences
30. Statins - The evidences
31. Statins - The evidences
32. The anti-statin lobby strikes again
33. Eur Heart J 2018
34. Eur Heart J 2018
35. Dyslipidaemias - Guidelines
36. LDL-C - Is lower better?
37. LDL-C - Is lower better?
38. Dyslipidaemias - Guidelines
39. Consultation "Lipides" aux HUG
40. CV risks are currently managed via diabetic and non-diabetic treatments
41. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
42. Conclusions
43. CV risks are currently managed via diabetic and non-diabetic treatments
44. Diabète & Cardiologue - Imagerie
45. Diabète & Cardiologue - Imagerie
46. Diabète & Cardiologue - Imagerie
47. Diabète & Cardiologue - Imagerie
48. Diabète & Cardiologue - Rythme
49. Enregistrement du rythme (Holter)
50. Conclusions/Messages
51. Conclusions/Messages
52. Bouger plusssssssss
53. Merci pour votre attention
54. URECA
55. Les adultes doivent montrer l'exemple!
56. Prévention cardiovasculaire
57. Dyslipidaemias - Guidelines
58. Les thérapies combinées sont éfficaces
59. PCSK9i - Indications and limits
60. PCSK9i - Indications and limits
61. Swiss recommendations 2016
62. Prévention Cardiovasculaire
63. Diabetes & CV risk of morbi-mortality
64. EMPA-REG OUTCOME was the first CVOT to show CV benefit
65. -
66. -
Pourquoi et quand consulter le cardiologue? Pr François Mach, 18.10.18
Resources
Here are some useful links and documents:
Title
Title
Title
FINISH
SUBMIT
NEXT
PREV
Submit All